Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
PaperCitations, authors & open-access status
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 187 citations, 2021 year and bronze oa status.
187
Citations
2021
Year
bronze
OA Status